References for this PMC Article for PMID: 23420874

Year	Number of Results
1990	1
1992	2
1993	3
1994	1
1995	2
1996	2
1997	1
1998	3
2000	3
2001	2
2003	4
2005	2
2006	1
2007	2
2008	5
2009	3
2010	6
2011	1
2012	1
2013	1
2024	0

1

Grb2 controls phosphorylation of FGFR2 by inhibiting receptor kinase and Shp2 phosphatase activity.

Ahmed Z, Lin CC, Suen KM, Melo FA, Levitt JA, Suhling K, Ladbury JE. Ahmed Z, et al. J Cell Biol. 2013 Feb 18;200(4):493-504. doi: 10.1083/jcb.201204106. J Cell Biol. 2013. PMID: 23420874 Free PMC article.

2

Inhibition of basal FGF receptor signaling by dimeric Grb2.

Lin CC, Melo FA, Ghosh R, Suen KM, Stagg LJ, Kirkpatrick J, Arold ST, Ahmed Z, Ladbury JE. Lin CC, et al. Cell. 2012 Jun 22;149(7):1514-24. doi: 10.1016/j.cell.2012.04.033. Cell. 2012. PMID: 22726438 Free article.

3

Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding.

Kleiman LB, Maiwald T, Conzelmann H, Lauffenburger DA, Sorger PK. Kleiman LB, et al. Mol Cell. 2011 Sep 2;43(5):723-37. doi: 10.1016/j.molcel.2011.07.014. Mol Cell. 2011. PMID: 21884975 Free PMC article.

4

FRS2α regulates Erk levels to control a self-renewal target Hes1 and proliferation of FGF-responsive neural stem/progenitor cells.

Sato T, Shimazaki T, Naka H, Fukami S, Satoh Y, Okano H, Lax I, Schlessinger J, Gotoh N. Sato T, et al. Stem Cells. 2010 Sep;28(9):1661-73. doi: 10.1002/stem.488. Stem Cells. 2010. PMID: 20652960 Free PMC article.

5

Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in "paternal age-effect" syndromes.

Goriely A, Lord H, Lim J, Johnson D, Lester T, Firth HV, Wilkie AO. Goriely A, et al. Am J Med Genet A. 2010 Aug;152A(8):2067-73. doi: 10.1002/ajmg.a.33513. Am J Med Genet A. 2010. PMID: 20635358 Free PMC article.

6

The tyrosine phosphatase Shp2 in development and cancer.

Grossmann KS, Rosário M, Birchmeier C, Birchmeier W. Grossmann KS, et al. Adv Cancer Res. 2010;106:53-89. doi: 10.1016/S0065-230X(10)06002-1. Adv Cancer Res. 2010. PMID: 20399956 Review.

7

FGFR2 mutations are rare across histologic subtypes of ovarian cancer.

Byron SA, Gartside MG, Wellens CL, Goodfellow PJ, Birrer MJ, Campbell IG, Pollock PM. Byron SA, et al. Gynecol Oncol. 2010 Apr;117(1):125-9. doi: 10.1016/j.ygyno.2009.12.002. Epub 2010 Jan 27. Gynecol Oncol. 2010. PMID: 20106510 Free article.

8

Fibroblast growth factor signalling: from development to cancer.

Turner N, Grose R. Turner N, et al. Nat Rev Cancer. 2010 Feb;10(2):116-29. doi: 10.1038/nrc2780. Nat Rev Cancer. 2010. PMID: 20094046 Review.

9

Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function.

Ahmed Z, George R, Lin CC, Suen KM, Levitt JA, Suhling K, Ladbury JE. Ahmed Z, et al. Cell Signal. 2010 Jan;22(1):23-33. doi: 10.1016/j.cellsig.2009.08.011. Epub 2009 Sep 6. Cell Signal. 2010. PMID: 19735729

10

Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma.

Gartside MG, Chen H, Ibrahimi OA, Byron SA, Curtis AV, Wellens CL, Bengston A, Yudt LM, Eliseenkova AV, Ma J, Curtin JA, Hyder P, Harper UL, Riedesel E, Mann GJ, Trent JM, Bastian BC, Meltzer PS, Mohammadi M, Pollock PM. Gartside MG, et al. Mol Cancer Res. 2009 Jan;7(1):41-54. doi: 10.1158/1541-7786.MCR-08-0021. Mol Cancer Res. 2009. PMID: 19147536 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

44 results

Results by year